Brightgene Pharmaceutical 483, Sep 2015

Brightgene Pharmaceutical 483, Sep 2015

Peter Baker FDA$119.00

FDA investigators audited the Brightgene Pharmaceutical - Suzhou, China facility and issued inspectional observations (via FDA 483) on 10 Sep 2015.

Add To Cart

Product details

  • Category: Human Drugs / Animal Drugs & Feeds
  • Inspection end: 10 Sep 2015
  • Location: Suzhou, China